MET and ovarian carcinoma: MiR-1 can suppress the growth of ovarian cancer cells by targeting p-Akt, p-ERK1/2, p-Rb, and CDK4 in HO-8910PM cells and suppress c-Met expression, which shows its inhibitory effect [17].